JAMA: New diabetes drugs may double the risk of pancreatitis
The class of diabetes medications known as GLP-1 agonists—which include Exenatide (Byetta, Bydureon) and Liraglutide (Victoza)—may significantly increase…
News Read MoreThe class of diabetes medications known as GLP-1 agonists—which include Exenatide (Byetta, Bydureon) and Liraglutide (Victoza)—may significantly increase…
News Read MoreGlenwood Gardens, Bakersfield, Calif., a Brookdale Senior Living independent living community, is defending one of its nurses who…
News Read MoreFor the first time in five years, the 30-day hospital readmission rate has dropped from an average of…
News Read MoreThe California Public Employees' Retirement System (CalPERS) plans to raise its rates for long-term care insurance by a…
News Read MoreCaring for aging Americans is getting more complicated. Some states are discussing the wisdom of mixing aging inmates…
News Read MoreWith the clock ticking to March 1 Medicare cuts to nursing homes resulting from the onset of the…
News Read MoreSkilled nursing facilities (SNFs) failed to meet their own basic care plans for more than one-third—37 percent—of their…
News Read MoreThe chemical resveratrol, found in red wine and red grapes can protect against hearing loss and cognitive decline,…
News Read MoreA $1.5 million budget to renovate the shared spaces of a public housing complex doesn’t come along every…
News Read More